Nextera

Using proprietary Phagemer technology to discover leukaemia antigens

placeOslo, Oslo, Norway calendar_todayFounded 2009 groups11 employees language nextera.no

Registered entities

Social engagement

Social engagement: 1.2K social following, 4 posts in the last 12 months — above the industry median.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital2100%

Recent activity

26 May 2026
Event
Antibody Engineering & Therapeutics Europe meeting
9 Nov 2025
Event
Accelerating and Improving Therapeutic Protein Discovery
7 Jul 2025
Partnership
Karolinska Institutet (Stockholm, Sweden)
Coming soon